Hepatitis C virus antibodies and other markers ofblood-transfusion-transmitted infection in multi-transfused Cuban patients

Ballester, José Manuel; Rivero, René A; Villaescusa, Rinaldo; Merlin, Júlio Cezar; Arce, Ada A.; Castillo, Dunia; Lam, Rosa María; Ballester, Adalberto; Almaguer, Miguel; Melians, Silvia M.; Aparicio, José Luis

doi:10.1016/s1386-6532(05)80033-2

Cited by 14 publications

(16 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The data from Iran seem to be lower than those from other countries of the region such as Kuwait (Al fuzae et al , 1998), Bahrain (AlMahroos & Ebrahimi, 1995) and Jordan (Al Sheyyab et al , 2001), with reports of 33 and 40% seropositivity, respectively, as well as the 50% seropositivity reported for patients from North India (Marwaha et al , 2003), 60% in Italian thalassaemics (Angeluce, 1994), 34% in haemoglobinopathy cases in Brazil (dePaula et al , 2005) and also from 34·1% reported for European patients in France, Italy and Belgium(deMotalambert et al , 1992). However, the results are close to those in Malaysia with 22·4% (Jamal et al , 1998)) and Cuba with 21·2% seropositive cases (Ballester et al , 2005). All the above reports similar to those of the groups from Iran, which include long‐term patients prior to anti‐HCV screening.…”

Section: Prevalence Of Tti In Mtps In Iransupporting

confidence: 81%

See 1 more Smart Citation

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Rezvan¹,

Abolghassemi²,

Amini-Kafiabad³

2007

Transfusion Medicine

View full text Add to dashboard Cite

Transfusion-transmitted infections (TTI) continue to be a major challenge for Blood transfusion organizations across the world. The problem is more serious in the developing countries with lower economic means. Multitransfused patients (MTPs) in these countries are at higher risk of infection, and studies of infection in these patients can be a useful index for examining the blood safety filters in place. The present article reviews the situation in Iran, where prevalence of the major viruses of concern, namely, hepatitis B virus, hepatitis C virus (HCV) and human immunodeficiency virus, studied in these patients is reported over a 9-year period. It is demonstrated that HCV is the most prevalent TTI and remains a major health problem for these patients.

show abstract

Section: Prevalence Of Tti In Mtps In Iransupporting

confidence: 81%

“…In a recent report from Cuba reporting 95·6% anti‐HCV positives in this group of patients have considered nosocomial transmission to be a very important problem (Ballester et al , 2005).…”

Section: Prevalence Of Tti In Mtps In Iranmentioning

confidence: 99%

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Rezvan¹,

Abolghassemi²,

Amini-Kafiabad³

2007

Transfusion Medicine

View full text Add to dashboard Cite

show abstract

“…It is only when a patient has been harboring the disease for anywhere between 20–40 years and therefore has a chronic HCV infection when noticeable symptoms or signs will occur. HCV is a significant “precursor” for fibrosis, cirrhosis, and ultimately, hepatocellular carcinoma, but it is important to understand this is only in long-term, chronic cases 20,25. In Egypt, up to 85% of HCV infections persist for life, leading to chronic hepatitis 20,27.…”

Section: Introductionmentioning

confidence: 99%

Hepatitis C in Egypt – past, present, and future

Elgharably¹,

Gomaa²,

Crossey³

et al. 2016

IJGM

156

130

View full text Add to dashboard Cite

Hepatitis C viral infection is endemic in Egypt with the highest prevalence rate in the world. It is widely accepted that the implementation of mass population antischistosomal treatment involving administration of tartar emetic injections (from 1950s to 1980s) led to widespread infection. What is less well known, however, is that these schemes were implemented by the Egyptian Ministry of Health on the advice of the World Health Organization. There has been a spectrum of treatments to target the public health disaster represented by the hepatitis C problem in Egypt: from the use of PEGylated interferon to the recent use of direct acting antiviral drugs. Some new treatments have shown >90% efficacy. However, cost is a key barrier to access these new medicines. This is coupled with a growing population, limited resources, and a lack of infection control practices which means Egypt still faces significant disease control issues today.

show abstract

“…viral hepatitis, cytomegalovirus, HIV infection, malaria, parvovirus B-19 etc.) is a serious problem in patients receiving chronic transfusions and undergoing invasive procedures with exposure of circulatory system [1][2][3]. The risk is higher among the subgroup of haemoglobinopathy subjects such as patients suffering from thalassemia and haemophilia [4].…”

Section: Introductionmentioning

confidence: 99%

A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India

Shrivastava

Kumar

Navaid

et al. 2014

Indian J Hematol Blood Transfus

View full text Add to dashboard Cite

show abstract

Hepatitis C virus antibodies and other markers ofblood-transfusion-transmitted infection in multi-transfused Cuban patients

Cited by 14 publications

References 22 publications

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Hepatitis C in Egypt – past, present, and future

A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India

Contact Info

Product

Resources

About

Hepatitis C virus antibodies and other markers ofblood-transfusion-transmitted infection in multi-transfused Cuban patients

Cited by 14 publications

References 22 publications

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Transfusion‐transmitted infections among multitransfused patients in Iran: a review

Hepatitis C in Egypt &ndash; past, present, and future

A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India

Contact Info

Product

Resources

About

Hepatitis C in Egypt – past, present, and future